Should we treat aging as a disease? The consequences and dangers of miscategorisation

Frontiers in Genetics

Volumn 6, Issue JUL, 2015, Pages

  Faragher, Richard G A ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Ethics; History; Medical; Philosophy; Rapamycin; Senescence; Werner syndrome

Indexed keywords

DASATINIB; EVEROLIMUS;

AGING; ARTICLE; CANCER GENETICS; CELL VIABILITY; CONCEPTUAL FRAMEWORK; DEGENERATIVE DISEASE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; MEDICALIZATION; SCURVY;

EID: 84940104506     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00171     Document Type: Article

References (39)

1. Achenbaum, W. A. (1995). Crossing Frontiers: Gerontology Emerges as a Science. Cambridge: Cambridge University Press.
2. Appleyard, B. (2007). How to Live Forever or Die Trying. London: Simon & Schuster.
3. Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., et al. (2011). Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232-236. doi: 10.1038/nature10600.
4. Bowling, A., and Dieppe, P. (2005). What is successful ageing and who should define it? Br. Med. J. 331, 1548-1551. doi: 10.1136/bmj.331.7531.1548.
5. Blackburn, S. (2001). Being Good: A Short Introduction to Ethics. Oxford: Oxford University Press.
6. Burton, D. G., Giles, P. J., Sheerin, A. N., Smith, S. K., Lawton, J. J., Ostler, E. L., et al. (2009). Microarray analysis of senescent vascular smooth muscle cells: a link to atherosclerosis and vascular calcification. Exp. Gerontol. 44, 659-665. doi: 10.1016/j.exger.2009.07.004.
7. Bury, M. (2005). Health and Illness. Cambridge: Polity Press.
8. Cockayne, K. (2003). Experiencing old Age in Ancient Rome Routledge Classical Monographs. London: Routledge.
9. Comas-Herrera, A., Wittenberg, R., Pickard, L., and Knapp, M. (2007). Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int. J. Geriatr. Psychiatry 22, 1037-1045. doi: 10.1002/gps.1830.
10. Comfort, A. (1956). Biology of Senescence. London: Reinhart & Company Inc.
11. Coppé, J. P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., et al. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868. doi: 10.1371/journal.pbio.0060301.
12. Crimmins, E. M. (2004). Trends in the health of the elderly. Annu. Rev. Public Health 25, 79-98. doi: 10.1146/annurev.publhealth.25.102802.124401.
13. De Grey, A., and Rae, M. (2007). Ending Aging: The Rejuvenation Breakthroughs that Could Reverse Human Aging in our Lifetime. Newyork, NY: St Martin's Griffin.
14. de Magalhães, J. P. (2014). The scientific quest for lasting youth: prospects for curing aging. Rejuvenation Res. 17, 458-467. doi: 10.1089/rej.2014.1580.
15. Fries, J. F. (1980). Aging, natural death, and the compression of morbidity. N. Engl. J. Med. 303, 130-135. doi: 10.1056/NEJM198007173030304.
16. Fries, J. F. (2005). Frailty, heart disease, and stroke: the Compression of Morbidity paradigm. Am. J. Prev. Med. 29, 164-168. doi: 10.1016/j.amepre.2005.07.004.
17. Herbig, U., Ferreira, M., Condel, L., Carey, D., and Sedivy, J. M. (2006). Cellular senescence in aging primates. Science 311:1257. doi: 10.1126/science.1122446.
18. Hessler, R. M., Eriksson, B. G., Dey, D., Steen, G., Sundh, V., and Steen, B. (2003). The compression of morbidity debate in aging: an empirical test using the gerontological and geriatric population studies in Göteborg, Sweden (H70). Arch. Gerontol. Geriatr. 37, 213-222. doi: 10.1016/S0167-4943(03)00048-7.
19. Ipsos-MORI. (2006). Public Consultation on Ageing: Research into Public Attitudes Towards BBSRC and MRC-Funded Research on Ageing Final Report. Goverment Report.
20. Jylhä, M. (2004). Old age and loneliness: cross-sectional and longitudinal analyses in the Tampere Longitudinal Study on Aging. Can. J. Aging 23, 157-168. doi: 10.1353/cja.2004.0023.
21. Kass, L. R. (2001). L'Chaim and its limits: why not immortality? First Things 113, 17-24.
22. Khaw, K. (1999). How many, how old, how soon? Br. Med. J. 319, 1350-1352. doi: 10.1136/bmj.319.7221.1350.
23. Kipling, D., Davis, T., Ostler, E. L., and Faragher, R. G. (2004). What can progeroid syndromes tell us about human aging? Science 305, 1426-1431. doi: 10.1126/science.1102587.
24. Kipling, D., Jones, D. L., Smith, S. K., Giles, P. J., Jennert-Burston, K., Ibrahim, B., et al. (2009). A transcriptomic analysis of the EK1. Br strain of human fibroblastoid keratocytes: the effects of growth, quiescence and senescence. Exp. Eye Res. 88, 277-285. doi: 10.1016/j.exer.2008.11.030.
25. Korenchevsky, V. (1961). Pathological and Physiological Ageing. London: Hafner Publishing Company.
26. Mannick, J. B., Del Giudice, G., Lattanzi, M., Valiante, N. M., Praestgaard, J., Huang, B., et al. (2014). mTOR inhibition improves immune function in the elderly. Sci. Transl. Med. 6, 268ra179. doi: 10.1126/scitranslmed.3009892.
27. NHS National Statistics. (2008). Prescriptions Dispensed in the Community Statistics for 1997 to 2007: England.
28. Pérès, K., Jagger, C., and Matthews, F. E. (2008). Impact of late-life self-reported emotional problems on Disability-Free Life Expectancy: results from the MRC Cognitive Function and Ageing. Int. J. Geriatr. Psychiatry 23, 643-649. doi: 10.1002/gps.1955.
29. Pew Research. (2013). Living to 120 and Beyond: Americans' Views on Aging, Medical Advances and Radical Life Extension. Available at: http://www.pewforum.org/2013/08/06/living-to-120-and-beyond-americans-views-on-aging-medical-advances-and-radical-life-extension/.
30. Piper, M. D., Selman, C., McElwee, J. J., and Partridge, L. (2008). Separating cause from effect: how does insulin/IGF signalling control lifespan in worms, flies and mice? J. Int. Med. 263, 179-191. doi: 10.1111/j.1365-2796.2007.01906.x.
31. Porter, R. (1999). The Greatest Benefit to Mankind: A Medical History of Humanity from Antiquity to the Present. London: Fontana Press.
32. Rowe, J. W., Wang, S. Y., and Elahi, D. (1990). "Design, conduct and analysis of human aging research," in Handbook of the Biology of Aging, 3rd Edn, eds E. L. Schneider and J. W. Rowe (San Diego: Academic Press Inc.), 63-70.
33. Selman, C., Lingard, S., Choudhury, A. I., Batterham, R. L., Claret, M., Clements, M., et al. (2008). Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22, 807-818. doi: 10.1096/fj.07-9261com.
34. Seshamani, M., and Gray, A. (2004). Ageing and health-care expenditure: the red herring argument revisited. Health Econ. 13, 303-314. doi: 10.1002/hec.826.
35. Shock, N. W., and Baker, G. T. (1988). The International Association of Gerontology: A Chronicle 1960-1986. Newyork, NY: Springer Publishing Company.
36. Shock, N. W., Greulich, R. C., Andres, R., Arenberg, D., Costa, P. T., Lakatta, E. G., et al. (1984). Normal Human Aging: The Baltimore Longitudinal Study of Aging. NIH Publications No. 84-2450.
37. Strawbridge, W. J., Wallhagen, M. I., and Cohen, R. D. (2002). Successful aging and well-being: self-rated compared with Rowe and Kahn. Gerontologist 42, 727-733. doi: 10.1093/geront/42.6.727.
38. Williams, G. C. (1957). Pleiotropy, natural selection and the evolution of senescence. Evolution 11, 398-411. doi: 10.2307/2406060.
39. Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A., Ding, H., Giorgadze, N., et al. (2015). The achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell doi: 10.1111/acel.12344 [Epub ahead of print].